Welcure Drugs & Pharmaceuticals Ltd — Updates, 05-08-2025: Company Update

Welcure Drugs & Pharmaceuticals announced strong financial results for the quarter, with Net Profit surging to Rs 23.29 crore, an 830% increase quarter-on-quarter. Revenue also significantly rose to Rs 299.91 crore, reflecting a 1300% jump from the previous quarter. This robust performance is driven by the company's strategic shift to a fee-based, export-oriented sourcing model. Welcure completed seven export-sourcing assignments totaling Rs 299.91 crore, earning a fixed 5% commission without exposure to inventory or working capital risks. A major Rs 517 crore global sourcing mandate is expected to further boost future service income. The company also appointed new directors to streamline governance.